Literature DB >> 28319458

Quality of Life in 807 Patients with Vestibular Schwannoma: Comparing Treatment Modalities.

Géke Soulier1, Bibian M van Leeuwen1, Hein Putter2, Jeroen C Jansen1, Martijn J A Malessy3, Peter Paul G van Benthem1, Andel G L van der Mey1, Anne M Stiggelbout4.   

Abstract

Objective In vestibular schwannoma treatment, the choice among treatment modalities is controversial. The first aim of this study was to examine the quality of life of patients with vestibular schwannoma having undergone observation, radiation therapy, or microsurgical resection. The second aim was to examine the relationship between perceived symptoms and quality of life. Last, the association between quality of life and time since treatment was studied. Study Design Cross-sectional study. Setting Tertiary referral center. Subjects and Methods A total of 1208 patients treated for sporadic vestibular schwannoma between 2004 and 2014 were mailed the disease-specific Penn Acoustic Neuroma Quality of Life (PANQOL) questionnaire and additional questions on symptoms associated with vestibular schwannoma. Total and domain scores were calculated and compared among treatment groups. Propensity scores were used, and results were stratified according to tumor size to control for potential confounders. Correlations were calculated to examine the relationship between self-reported symptoms and quality of life, as well as between quality of life and time since treatment. Results Patients with small tumors (≤10 mm) under observation showed a higher PANQOL score when compared with the radiation therapy and microsurgical resection groups. A strong negative correlation was found between self-reported symptoms and quality of life, with balance problems and vertigo having the largest impact. No correlation was found between PANQOL score and time since treatment. Conclusion This study suggests that patients with small vestibular schwannomas experience better quality of life when managed with observation than do patients who have undergone active treatment.

Entities:  

Keywords:  PANQOL; quality of life; treatment; vestibular schwannoma

Mesh:

Year:  2017        PMID: 28319458     DOI: 10.1177/0194599817695800

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

1.  Risk Recall of Complications Associated with Vestibular Schwannoma Treatment.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Omid Moshtaghi; Marlon Maducdoc; Brandon M Lehrich; Harrison W Lin; Hamid R Djalilian
Journal:  Otolaryngol Head Neck Surg       Date:  2019-03-19       Impact factor: 3.497

2.  The changing landscape of vestibular schwannoma diagnosis and management: A cross-sectional study.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Omid Moshtaghi; Ronald Sahyouni; Autefeh Sajjadi; Harrison W Lin; Hamid R Djalilian
Journal:  Laryngoscope       Date:  2019-04-05       Impact factor: 3.325

3.  Analyzing patient experiences using natural language processing: development and validation of the artificial intelligence patient reported experience measure (AI-PREM).

Authors:  Marieke M van Buchem; Olaf M Neve; Ilse M J Kant; Ewout W Steyerberg; Hileen Boosman; Erik F Hensen
Journal:  BMC Med Inform Decis Mak       Date:  2022-07-15       Impact factor: 3.298

4.  Cochlear Implantation in Vestibular Schwannoma: A Systematic Literature Review.

Authors:  Kent Tadokoro; Matthew Robert Bartindale; Nadeem El-Kouri; Dennis Moore; Christopher Britt; Matthew Kircher
Journal:  J Neurol Surg B Skull Base       Date:  2021-06-08

5.  Quality of life, social function, emotion, and facial paresis in Dutch vestibular schwannoma patients.

Authors:  Stephanie S A H Blom; Henk Aarts; Capi C Wever; Henricus P M Kunst; Gün R Semin
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-04-17

6.  Severity of Tinnitus Distress Negatively Impacts Quality of Life in Patients With Vestibular Schwannoma and Mimics Primary Tinnitus.

Authors:  Takashi Kojima; Naoki Oishi; Takanori Nishiyama; Kaoru Ogawa
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

7.  Identification of Differentially Expressed miRNAs and mRNAs in Vestibular Schwannoma by Integrated Analysis.

Authors:  Yanhua Lei; Ping Guo; Xiuguo Li; Yuanyuan Zhang; Ting Du
Journal:  Biomed Res Int       Date:  2019-06-11       Impact factor: 3.411

8.  Long non-coding RNA BRCAT54 sponges microRNA-21 in vestibular schwannoma to suppress cell proliferation.

Authors:  Gang Xiao; Bin Huang; Ming Guo; Chaoxin Long; Pingan Li; Bin Zhong; Chuncheng Guan
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.